
Opinion|Videos|August 1, 2024
Key Considerations for Selecting IPF Treatment
Author(s)Justin Oldham, MD, MS
Decision-making factors surrounding optimal IPF treatment selection are evaluated by Justin Oldham, MD, MS.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Based on your clinical experience, what patient characteristics are considered when selecting a treatment regimen?
- What challenges are often present with current antifibrotic agents (i.e., tolerability, adverse effects)?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
2
FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population
3
FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer
4
Patients Face New Care Complexities as DTC Options Expand
5
















































